Principal Securities’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Principal Securities’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,370	Closed	-$1.02K	–	3929
2025 Q1	$1.02K	Hold	1,370	–	–	﹤0.01%	3206
2024 Q4	$1.02K	Hold	1,370	–	–	﹤0.01%	3199
2024 Q3	$1.67K	Buy	+1,370	New	+$2.18K	﹤0.01%	3004

Principal Securities's OMGA Position: Q2 2025 in Review

Principal Securities sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2025, closing a stake of 1,370 shares — an estimated $1.02K sold.

Principal Securities first reported a position in OMGA in Q3 2024 and held it in 3 quarters. The position peaked at $1.67K in Q3 2024. 1 fund tracked by Wall St. Rank holds OMGA as of Q2 2025.

Principal Securities reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Principal Securities sold 1,370 Omega Therapeutics, Inc. Common Stock shares in Q2 2025, an estimated $1.02K.
Principal Securities first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2024 and held it in 3 quarters.
Principal Securities's Omega Therapeutics, Inc. Common Stock position peaked at $1.67K in Q3 2024.
1 fund tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2025.

Based on Principal Securities's 13F filing for Q2 2025, filed 11 Aug 2025.